Articles T67 Số CDD10 - HN Bệnh viện Nhi Đồng 2 - HN Trường Đại học Nguyễn Tất Thành

PATIENT CHARACTERISTICS AND PROCALCITONIN–CURB-65 CORRELATION IN COMMUNITY-ACQUIRED PNEUMONIA.

Hoang Van Loc1,2, Hoang Van Quang1,2,3,4, Nguyen Binh Kim Ngan1,2, Lam Thanh Tam1,2, Tran Le Han1,2
1 Nguyen Tat Thanh University
2 Trường Đại học Nguyễn Tất Thành
3 Thong Nhat Hospital
4 Bệnh viện Thống Nhất
DOI: 10.52163/yhc.v67icd10.6204
0 Views
0 Downloads
Keywords
Community-acquired pneumonia, PCT, CURB-65.
Abstract

Objective:
To investigate the correlation between Procalcitonin (PCT) and the CURB-65 score in patients with community-acquired pneumonia at Thong Nhat Hospital.

Subjects and Methods:
A prospective, cross-sectional study of 92 patients with community-acquired pneumonia (CAP), admitted to Thong Nhat Hospital from September 1, 2025, to December 30, 2025. PCT testing and CURB-65 scoring were performed at the time of hospital admission.

Results:
The median age was 76.9 years, with males accounting for 56.5%. The moyen CURB-65 score was 2.42. Common clinical symptoms included fever (87.8%), cough with phlegm (87%), and dyspnea (67.4%). The rate of septic shock was relatively low at 12%. The predominant radiological findings were bilateral alveolar and interstitial infiltrates. The median PCT level was 12.2 ng/mL. Higher CURB-65 scores were associated with higher PCT levels, showing a weak positive correlation (r = 0.239, p = 0.022).

Conclusion:
Community-acquired pneumonia is a common condition in clinical practice. PCT levels show a weak positive correlation with the CURB-65 score. Therefore, multiple indicators should be combined to assess disease severity.

References
[1]
Tạ Thị Diệu Ngân. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và căn nguyên của viêm phổi mắc phải tại cộng đồng. Luận án tiến sĩ Y học. Đại học Y Hà Nội năm 2016. Google Scholar
[2]
Y. Song, Sun W., Dai D., et al. Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia. Expert Review of Respiratory Medicine. 2021;15(5):689-696. doi: 10.1080/17476348.2021.1865810. Google Scholar
[3]
L. A. Mandell, Wunderink R. G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases. 2007; 44: 22-72. Google Scholar
[4]
doi: 10.1086/511159. Google Scholar
[5]
J. P. Metlay, Waterer G. W., Long A. C., et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. American journal of respiratory and critical care medicine. 2019; 200(7): e45-e67. doi: 10.1164/rccm.201908-1581ST. Google Scholar
[6]
D. Miteva, Radkov Y., Ivanova L. Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia. European Respiratory Journal. 2016;48(60):2589. DOI:10.1183/13993003.congress-2016.PA2589. Google Scholar
[7]
F. Keramat, Ghasemi Basir H. R., Abdoli E., Shafiei Aghdam A., Poorolajal J. Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia. International Journal of General Medicine. 2018:217-223. doi: 10.2147/IJGM.S165190. eCollection 2018. Google Scholar
[8]
S. Lindstrom, Wong E. Procalcitonin, a valuable biomarker assisting clinical decision‐making in the management of community‐acquired pneumonia. Internal medicine journal. 2014;44(4):390-397. doi: 10.1111/imj.12374. Google Scholar
[9]
Nguyễn Văn Tuấn, Trần Thị Kiều Anh. Nghiên cứu đặc điểm lâm sàng và cận lâm sàng của bệnh nhân viêm phổi mắc phải cộng đồng tại bệnh viện hữu nghị đa khoa Nghệ An. Tạp chí Y học Việt Nam. 2021;505(1). DOI: https://doi.org/10.51298/vmj.v505i1.1062 Google Scholar
[10]
Wendy I Sligl, Thomas J Marrie. Severe Community-Acquired Pneumonia. Crit Care Clin, 2013 Jul 4;29(3):563–601. doi: 10.1016/j.ccc.2013.03.009 Google Scholar
[11]
Từ Quốc Thanh, Cao Thị Bích Ngân, Võ Thị Vân, Nguyễn Thị Bạch Tuyết, Đoàn Thị Minh Liên, Nguyễn Thị Phương Thảo. Vai trò của Procalcitonin trong tiên lượng bệnh viêm phổi mắc phải cộng đồng tại bệnh viện Trưng Vương. Y Học TP. Hồ Chí Minh, Tập 20, Số 5, 2016: 1-9 Google Scholar